...Evan Seigerman All right. We made it to the final session of our Oncology Summit. And last and certainly not least is Incyte. So from Incyte, we have a full house, but I'll introduce Herve Hoppenot, Chairman, President and CEO; Steven Stein, Chief Medical Officer; and Christiana Stamoulis, CFO; and of course, the fabulous IR team. Thank you guys for joining me. I really like this setup. It's nice to have everyone on one panel. Before we jump in, I just want to address a few housekeeping items, and then we can go into Q&A. On the Webex, if you'd like to ask a question, there is a mechanism to do so. You can also e-mail me, evan.seigerman@bmo.com, and I'm happy to ask on your behalf. And thank you, everyone, for joining us. We were just talking before the session started about how we want to do this in person next time, how -- too many months of Zoom and Webex calls at this point. But thank you, guys, for joining. We're glad you're here. So Herve, before we... Herve Hoppenot ...